1. Home
  2. ACOG vs JSPR Comparison

ACOG vs JSPR Comparison

Compare ACOG & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • JSPR
  • Stock Information
  • Founded
  • ACOG 2000
  • JSPR 2018
  • Country
  • ACOG Canada
  • JSPR United States
  • Employees
  • ACOG N/A
  • JSPR N/A
  • Industry
  • ACOG
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACOG
  • JSPR Health Care
  • Exchange
  • ACOG Nasdaq
  • JSPR Nasdaq
  • Market Cap
  • ACOG 80.3M
  • JSPR 85.8M
  • IPO Year
  • ACOG N/A
  • JSPR N/A
  • Fundamental
  • Price
  • ACOG $7.43
  • JSPR $4.52
  • Analyst Decision
  • ACOG Strong Buy
  • JSPR Strong Buy
  • Analyst Count
  • ACOG 1
  • JSPR 10
  • Target Price
  • ACOG $20.00
  • JSPR $62.50
  • AVG Volume (30 Days)
  • ACOG 80.6K
  • JSPR 155.7K
  • Earning Date
  • ACOG 05-15-2025
  • JSPR 05-20-2025
  • Dividend Yield
  • ACOG N/A
  • JSPR N/A
  • EPS Growth
  • ACOG N/A
  • JSPR N/A
  • EPS
  • ACOG N/A
  • JSPR N/A
  • Revenue
  • ACOG N/A
  • JSPR N/A
  • Revenue This Year
  • ACOG N/A
  • JSPR N/A
  • Revenue Next Year
  • ACOG N/A
  • JSPR N/A
  • P/E Ratio
  • ACOG N/A
  • JSPR N/A
  • Revenue Growth
  • ACOG N/A
  • JSPR N/A
  • 52 Week Low
  • ACOG $3.75
  • JSPR $3.13
  • 52 Week High
  • ACOG $7.00
  • JSPR $26.84
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • JSPR 46.13
  • Support Level
  • ACOG N/A
  • JSPR $4.27
  • Resistance Level
  • ACOG N/A
  • JSPR $5.67
  • Average True Range (ATR)
  • ACOG 0.00
  • JSPR 0.43
  • MACD
  • ACOG 0.00
  • JSPR -0.01
  • Stochastic Oscillator
  • ACOG 0.00
  • JSPR 22.56

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: